Latest Report Available at Analytical Research Cognizance, “Alzheimer’s Disease Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
Alzheimer’s Disease: Competitive Landscape to 2026
Alzheimer’s disease (AD) Market is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The degeneration of neurons starts in the brainstem before progressing to the hippocampus, frontal lobe, amygdala, parietal lobe, and temporal lobe. The cause of AD is unknown, but it appears to be multifactorial, with most research aimed at the A? peptides and tau proteins. The irregular clearance and metabolism of these proteins are likely contributors to the presentation of the disease. The risk of developing AD is believed to be determined by a combination of genetic, metabolic, behavioral, and environmental factors.
This report provides an assessment of the pipeline, clinical, and commercial landscape of AD. Overall, GlobalData expects new drug approvals to drive AD market growth over the next decade (2016-2026).
Scope
This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include –
– Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type
– Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
– Commercial Assessment: leading marketed products, current and future players
– Competitive Landscape Analysis: key market events (2016-2026).
Request a sample of this report @ http://www.arcognizance.com/enquiry-sample/94118
Reasons to buy
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global AD market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global AD market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Companies Mentioned:
Biogen
Eisai Co.
F. Hoffmann-La Roche
Otsuka Pharmaceuticals
Eli Lilly
Ionis Pharmaceuticals
TauRx Therapeutics
Axsome Therapeutics
Accera
Novartis
AZTherapies
AB Science
Grifols
Shanghai Green Valley Pharmaceutical
Archer Pharmaceuticals
Changchun Huayang High-Tech
Intra-Cellular Therapies
Avanir Pharmaceuticals
Promis Neurosciences
Pfizer
Johnson & Johnson
AstraZeneca
Janssen
Allergan
Adamas Pharmaceuticals
Lundbeck
Merz Pharma GmbH
Icure Pharmaceutical
Shire
Chase Pharmaceuticals
Purchase copy of this Report @ http://www.arcognizance.com/purchase/94118
Some Points from Toc:
- Preface 2
1.1 Table of Contents 2
1.2 Abbreviations 3
1.3 Related Reports 4
1.4 Upcoming Related Reports 5 - Executive Summary 6
2.2 Key Findings 7
2.2 Key Events 8 - Introduction 9
3.1 Report Scope 10
3.2 Disease Overview and Epidemiology 12 - Pipeline Assessment 15
4.1 Pipeline Overview 16
4.2 Pipeline Breakdown by Region/Country 18
4.3 Pipeline Breakdown by Molecule Type and Target 19
4.4 Drug Review Designations 20
4.5 Products in Clinical Development 21 - Clinical Trial Assessment 23
5.1 Clinical Trials Overview 24
5.2 Top Sponsors of Clinical Trials in AD 25
5.3 Trial Breakdown by Region 27
5.4 Therapy Area Perspective 28
5.5 Enrollment Analytics 29
6 Commercial Assessment 32
6.1 Leading Marketed Products 33
6.2 Current & Future Players 34
About US:
www.arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics“ based on the data collection facilities of big data, the face of „business research facilities“ has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the „out of the box“ developments in the market.
Contact US:
Name: Analytical research cognizance
Address: 100 Church Street,
8th floor, Manhattan,
New York 10007
Phone: +1 (646) 434-7969 +91 90967 44448
Email: enquiry@arcognizance.com